Suzanne Davis and Elizabeth Walker discuss the diagnosis and classification of epilepsy syndromes, and the indications and adverse effects of anti-seizure medications. They also review self-management and lifestyle issues for people with epilepsy
All medicines containing codeine were reclassified as prescription medicines on 5 November 2020. Clinical advisory pharmacists Linda Bryant and John Dunlop discuss reasons for this decision and provide tips for pharmacists to help patients with the transition
This article, by consultant neurologist John Mottershead, looks briefly at the aetiology, pathophysiology and diagnosis of multiple sclerosis before exploring the approaches for treating relapses and symptoms of MS. It also discusses current disease-modifying treatments in detail
Consultant paediatrician Rebecca Hayman and house officer Melissa Hassan describe how you can help children and their whānau manage constipation, a common and challenging problem
This article, written by specialist dermatologist Louise Reiche, aims to help pharmacists better understand the pathogenesis of psoriasis, feel confident about the available treatment options and provide the best advice to patients
In this article, Christchurch pharmacist Sarah Mooney explores how pharmacies can support women and couples during the period from preconception to birth
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes